With the acquisition of a leading scientific cannabinoid testing facility, BRITISH CANNABIS takes its track record for having the most rigorously tested CBD products in the market and amplifies it tenfold. This can strengthen confidence that consumers and business partners have in the reliability of cannabinoid [...]
Via Newsweed New information suggests that the Macron government will not support the general legalisation of medical cannabis in France when the ongoing trial ends in 2024. French media outlet Newsweed reports that the future Social Security Financing Bill (PLFSS) will not include a budget for [...]
A new study is the first to explore the role of cannabinoids in treating critically ill patients, with doctors calling for further research in this area. For the first time researchers have explored the therapeutic potential of cannabinoids in critically ill patients in intensive care. The [...]
When Texas Governor Greg Abbott signed Senate Bill 339, also known as the Texas Compassionate Use Act, into law in 2015, many Texans expressed frustration. The purpose of the act was to allow the THC treatment of illness via prescription, opening up the state’s medicinal cannabis [...]
A new review has published recommendations for the maximum daily CBD intake, with up to 160mg found to be acceptable for ‘healthy’ adults. The scientific review was commissioned by cannabis companies, Canopy Growth and Charlotte’s Web, to develop recommendations for oral doses of CBD isolate. Researchers [...]
In Maine, a laboratory released a study they conducted, finding a 17% failure rate of dangerous pesticides in cannabis samples tested. The state requires testing for adult use cannabis, but not for medical cannabis. Just under 4% of adult use samples failed a pesticide screening, while [...]
Joe* speaks to Cannabis Health about how his prescription has enabled him to live a full life despite the debilitating symptoms brought on by vestibular migraines. Joe, 29, began experiencing vestibular migraines whilst at university. Sometimes they would last for months at a time and leave [...]
New research suggests cannabis may go some way to reducing the risk of developing Type 2 diabetes, while other studies shed light on its potential in fibromyalgia, autism and skin disorders. A wealth of cannabis-related research has been published over the last few months, including studies [...]
Via Cannareporter One of Portugal’s major political parties is to establish a working group to explore the possibility of legalising cannabis for non-medical purposes, in collaboration with other parliamentary groups. The regulation of recreational cannabis in Portugal may be imminent, following the European trend to review [...]
Dutch officials have announced that the country’s cannabis legalisation experiment will begin its pilot phase before the end of the year. Initially approved by the senate in 2019, the Wietexperiment [Weed Experiment] will see a select number of cultivators permitted to supply legal cannabis to coffee [...]
New findings related to how the body’s endocannabinoid system responds to stress could open a new avenue of drug development to treat psychiatric disorders, say researchers. Scientists believe that when an individual is under stress the brain may release its own cannabinoid molecules to calm them [...]
While not as well-known as CBD or THC, raw cannabinoids such as cannabidiolic acid (CBDA), are becoming more popular due to their potential health and wellness benefits. The term ‘raw cannabinoids’ refers to the chemical compounds found in the cannabis plant in their natural form, before [...]
UK medical cannabis company, Lyphe Group, has announced a new partnership to enhance how patients receive their cannabis prescriptions. In what is thought to be an industry first, Lyphe Group’s dispensing pharmacy, Dispensary Green, has partnered with Boveda Inc, a global leader in two-way humidity control, [...]
Approaching five years since medical cannabis was legalised in the UK, a new BBC documentary accuses the government of misleading the public over its availability on the NHS. On 1 November, 2023 medical cannabis will have been legally available on prescription in the UK for five [...]
Researchers have received a $3.69 million grant from the National Institute on Drug Abuse (NIDA) to study how genetic differences influence behavioural and physiological responses to tetrahydrocannabinol (THC). Increased legalisation of medical and/or recreational cannabis and more favourable public perspectives has led to an increase in [...]
Adult-use cannabis has gained steam across the nation as more and more states jump on the legalization train. As of the writing of this article, 23 states have legalized adult-use while another 15 have allowed the sale of cannabis for medicinal purposes, for a total of [...]
Researchers behind a new study say medicinal cannabis is not only effective and fast-acting in the treatment of neuropathic pain, but also has fewer side-effects than conventional medicines. A retrospective study, conducted by scientists from the University Medical Center Hamburg-Eppendorf (UKE Hamburg) in Germany in cooperation [...]
In the most unexpected development to hit the cannabis industry in years, the U.S. Department of Health and Human Services’ (HHS) Secretary Xavier Becerra shared his agency’s recommendation that, based on data and scientific analysis, cannabis, a Schedule I drug under the Controlled Substances Act, should [...]
CanXChange, the largest B2B cannabis platform in Europe and a leading financial technology company, is proud to announce the launch of its newest service, CX Financing. This innovative product is set to transform the receivables financing landscape, offering exclusive credit terms to our esteemed partners and [...]
After years of pain medication and antidepressants, Kerry Davies came off all her NHS prescription drugs when she started consuming cannabis medicinally. Here, she shares her journey so far. Kerry Davies battles daily with the symptoms of fibromyalgia and PTSD, as well as her history of [...]
This is the final piece of a four-part series discussing European cannabis regulations. Click here for Part One, here for Part Two and here for Part Three. Part Four wraps up the series below. Where is the future of CBD heading? A review of these various jurisdictions, the EU, [...]
Part 1 of this series discussed the lack of bankruptcy protections for cannabis companies, since bankruptcy in the U.S. is an exclusively federal procedure and cannabis remains illegal under federal law and proposed a number of alternative options for businesses struggling in the current environment. Part [...]
Researchers in Germany have shed new light on how cannabinoids could potentially reduce inflammation in the body, with CBD found to be particularly effective. Friedrich-Schiller-Universitaet Jena in Germany, have been investigating how certain compounds found in the cannabis plant work to counteract inflammation in the body. [...]
We bring you the news you might have missed from the week just gone. The top lines: Health officials in the US have recommended that cannabis be rescheduled to a ‘lower risk’ drug, while the UK Home Affairs Committee called for wider access to cannabis on [...]
Via Business of Cannabis As Switzerland sees the launch of its second cannabis pilot, Cannavigia co-founder Philipp Hagenbach, shares his insights on the country’s approach to reform. Recent weeks have seen the launch of ZüriCan, Switzerland’s second cannabis pilot set to give over 2,000 Zurich inhabitants [...]
Employers may be breaching the Equality Act over their approach to prescription cannabis patients in the workplace, according to a new report. What are your rights as an employer and an employee? Published by the Cannabis Industry Council (CIC), ‘The Use of Prescription Cannabis at Work’, [...]
Australian patients with chronic health issues showed significant improvements in overall health-related quality of life and fatigue in the first three months of treatment with medical cannabis, a new study has found. The paper, published in the journal PLOS ONE, also noted that participants reported improvements [...]
Endometriosis is a chronic inflammatory disorder that affects 10% of all women between the ages of 12 and 80 years old and for which there is an urgent need for new treatment options. Here, experts at SOMAÍ Pharmaceuticals explore how cannabis could be part of the [...]
With cannabis use reaching its highest recorded levels among older adults in the US, this generation may finally be recognising its potential enhancing health and wellbeing. Insights from a recent federally-funded survey in the US suggest that cannabis use has risen significantly in the last decade, [...]
This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part Three dives into dosage, approvals and more. Stay tuned for the final Part Four, coming next week. But does CBD harm the liver? Here, [...]
The role of cannabis-based medicines in treating the symptoms of Long Covid warrants further investigation, according to a new review. UK researchers say existing evidence supports the use of cannabis as a potential treatment for Long Covid, including for symptoms of sleep disturbance, fatigue, pain and [...]
Recently, Congress requested detailed information regarding the regulation of CBD and other cannabinoids. This comes on the heels of frustration around federal inaction with regards to cannabinoid-containing products produced from Cannabis sativa L. plant extracts that can be classified as “hemp” products amidst the clear need [...]
Vaping is a popular way of consuming CBD, but there’s a dark side to the disposable vapes which have flooded the market in recent years. As we previously explored, vaping is an increasingly popular way of administering CBD, mainly due to its fast-acting effects and its [...]
In its latest report on drugs, the UK Home Affairs Committee recommends that the government widens access to cannabis medicines on the NHS, but cites ‘concerns’ over non-medical use. The new report, published by the Home Affairs Committee on Thursday 31 August, sets out a number [...]
Part 1 of this series discussed the lack of bankruptcy protections for cannabis companies, since bankruptcy in the U.S. is an exclusively federal procedure and cannabis remains illegal under federal law and proposed a number of alternative options for businesses struggling in the current environment. Part [...]
The US Department of Health and Human Services (HHS), has recommended that cannabis be classed as a lower risk drug. Here’s what this means for research, industry and consumers. A leaked letter, seen by Bloomberg News and dated Tuesday 29 August, reveals that the HHS has [...]
A new report explores the progression of cannabis research over the last decade, as well as the barriers holding back further developments in the pharmaceutical space. We take a look at some of the key takeaways. The report, published today by Prohibition Partners and Cannabiscientia, gives [...]
Cannabinoids may be beneficial for managing symptoms in children with cancer, a new review finds, but more extensive research is needed. A recent analysis of existing research suggests that while cannabinoids are increasingly being used to manage symptoms in childhood cancer, there is a lack of [...]
Massively promising news for the cannabis industry today that many are calling historic: the Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA), recommending that cannabis be rescheduled from Schedule I to Schedule III. The news was originally [...]
In the wake of the 2018 Farm Bill, the horizons of hemp-derived cannabis products expanded, offering nearly limitless opportunities for businesses and brands in the CBD industry to expand what they could offer to their customers. However, threading the path to prosperity within this new regime [...]
Representatives of the UK CBD industry are urging the Home Office to protect the sector, and reassure millions of consumers, with greater clarity and stricter regulation. A new campaign, led by the Association for the Cannabinoid Industry (ACI), is calling on the Home Office to implement [...]
In a new study, cannabis was not associated with increased rates of psychosis or other adverse health outcomes among adolescents classed as ‘high risk’ for the disorder. Researchers at Hofstra University in New York and Stanford University in California, assessed the relationship between cannabis use and [...]
Here we are again, crossing our fingers, hoping that the Senate will approve the passage of the Secure and Fair Enforcement Banking Act (SAFE Banking Act). This Act would provide banks with regulatory protections, allowing them to offer critical financial services to cannabis businesses without risking [...]
In any industry that is labeled as the “Wild West,” the ability to discern your target market, collect accurate data and strategically drive success has become paramount. With factors such as invisible shoppers, anyone who is a customer of a brand or dispensary and does not [...]
This is Part Two of a four-part series discussing European cannabis regulations. Click here for Part One. Part Two analyzes the differences between the UK, the EU and the US. Part Three, coming next week, dives into dosage, approvals and more. Stay tuned for more. EU [...]
We bring you the news you might have missed from the week just gone. The top lines this week: The Swiss city of Zürich launches its adult-use cannabis pilot, Israel’s major reforms aim to make medical cannabis a ‘first line treatment’, and a global study will [...]
Via Business of Cannabis Israel could soon see a dramatic increase in the number of medical cannabis patients as the government publishes proposals for sweeping reforms aimed at streamlining access. On Monday 7 August, The Health Ministry published its highly anticipated proposals for medical cannabis reform in [...]
In his final instalment, consultant psychiatrist and cannabis clinician Dr Tahzid Ahsan, explores the potential of cannabis in managing symptoms of ADHD and autism. Around three in 10 autistic adults and around 28% of autistic children also have ADHD. The likelihood of someone presenting with both [...]
Cannabis scientist Lex Pelger brings you the latest cannabinoid research with new studies exploring CBD for ageing and hair growth, plus fibromyalgia, Alzheimer’s, binge eating disorder and more. Lex Pelger is a biochemist specialising in cannabinoids and psychedelics. Here we share an extract from his newsletter, [...]
The Swiss city of Zurich has marked a significant milestone with the official launch of its cannabis pilot trial ‘ZüriCan’ this week. The trials represent a major development in the legalisation and regulation of cannabis in Switzerland. The second pilot, which began on Tuesday 22 August, [...]
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
